Toru Tateno

Contact

Assistant Professor, Faculty of Medicine & Dentistry - Medicine Dept

Email: tateno@ualberta.ca

Overview

Area of Study / Keywords

pituitary tumors hormone regulation endocrine tumors biomarkers drug discovery cancer treatment

About

Personal Statement:

Pituitary tumours affect nearly 17 percent of the population with life-changing consequences. There are currently no effective treatments for these tumours. My research investigates the causes and effects of pituitary tumours in the endocrine system with the goal of developing a robust tumour model that is the necessary first step to developing therapies.

Clinician-scientist: I completed my medical degree and clinical training at the Tokyo Medical and Dental University. I then completed postdoctoral and clinical fellowships at the University of Toronto before coming to the University of Alberta to complete a research fellowship. I was appointed an assistant professor in 2017. My clinical and research focus is identifying new biomarkers for and developing new therapies to treat pituitary tumours.

Leadership and Collaborations:

I am a member of the Women and Children’s Health Research Institute and the Cancer Research Institute of Northern Alberta.

Clinical Interests

I am interested in pituitary disorders, mainly pituitary tumors, including Cushing’s disease, acromegaly, prolactinoma, TSH-producing pituitary adenoma, non-functioning pituitary adenoma, and aggressive pituitary tumors.

Teaching

Most of my teaching is done in clinics.

Featured Publications

Role of XBP1-IRE1a pathway in rodent functional pituitary tumor cells.

ENDO 2022. 2022 June;

IRE1a-XBP1s pathway in mouse ACTH-producing pituitary tumor cells

ME2 MAJUMDAR RESEARCH & QUALITY IMPROVEMENT DAY. 2022 May;

Co-morbidity Assessment in Acromegaly: Colonoscopy Versus Osteoarthropathy

The annual meeting of the Canadian Society of Endocrinology and Metabolism 2020. 2020 October;